Selected Publications
Markman TM, Khoshknab M, Santangeli P, Marchlinski FE, Nazarian S.: Feasibility of Computed Tomography-Guided Cardioneuroablation for Atrial Fibrillation JACC Clin Electrophysiol : 2022.
Markman TM, Folse E, Yang L, Groeneveld PW, Frankel DS.: Trends in Opioid Use After Cardiac Implantable Electronic Device Procedures in the United States Between 2004 and 2020 Circulation 145 : 1499-1501,2022.
Markman TM, Pothineni NVK, Zghaib T, Smietana J, McBride D, Amankwah NA, Linn KA, Kumareswaran R, Hyman M, Arkles J, Santangeli P, Schaller RD, Supple GE, Frankel DS, Deo R, Lin D, Riley MP, Epstein AE, Callans DJ, Marchlinski FE, *Hamilton R, *Nazarian S: Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm: A Randomized Clinical Trial JAMA Cardiol 7 : 445-449,2022.
Zghaib T, Markman TM, Nazarian S.: All That Glitters Is Not Scar Circ Arrhythm Electrophysiol : 2022.
Markman TM, John L, Kalluri AG, Tzou WS, Badertscher P, Winterfield J, Partington SL, Santangeli P, Chung FP.: Catheter Ablation of Ventricular Arrhythmias With Indirect Evidence of Critical Substrate Elements Protected by Prosthetic Material JACC Clin Electrophysiol : 2022.
Markman TM, Brozoski J, Bode W, Nazarian S.: A novel use of a subcutaneous implantable cardioverter-defibrillator algorithm to detect bradycardia HeartRhythm Case Rep 8 : 164-166,2021.
Markman TM, Brown CR, Yang L, Guandalini GS, Hyman MC, Arkles JS, Santangeli P, Schaller RD, Supple GE, Deo R, Nazarian S, Dixit S, Callans DJ, Epstein AE, Marchlinski FE, Groeneveld PD, Frankel DS: Persistent Opioid Use After Cardiac Implantable Electronic Device Procedures Circulation 144 (20): 1590-1597,2021.
Smietana JJ, Garcia FC, Pothineni NVK, Busk K, Khoshknab M, Markman TM, Santangeli P, Dixit S, Marchlinski F, Tschabrunn C, Nazarian S: Feasibility of "natural surface" epicardial mapping from the pulmonary artery for management of atrial arrhythmias Heart Rhythm O2 2 (6Part A): 578-587,2021.
Markman TM, Smietana J, Epstein AE: A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change HeartRhythm Case Rep 7 (8): 562-565,2021.
Markman TM, Smietana J, Epstein AE: A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change HeartRhythm Case Rep 7 (8): 562-565,2021.
Academic Contact Information
Hospital of the University of Pennsylvania
1 Convention Avenue
Philadelphia,
PA
19104
Phone: 215-615-4332
Patient appointments: 800-789-7366